Skip to Main Content

INFORMATION FOR

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Conditions

Diseases of the Nervous System

Phase Pilot

What is the purpose of this trial?

The eShunt® System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and the eShunt Implant, a permanent implant deployed in a minimally invasive, neuro-interventional procedure. The eShunt System is intended to shunt cerebrospinal fluid from the intracranial subarachnoid space to the venous system for the treatment of patients with normal pressure hydrocephalus, reducing disability due to symptoms including one or more of gait disturbance, cognitive dysfunction and urinary incontinence.

  • Trial with
    CereVasc, Inc.
  • Start Date
    04/20/2022
  • End Date
    08/01/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000032178